Granahan Investment Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-821,306
| Closed | -$8.06M | – | 194 |
|
|
2023
Q4 | $8.06M | Buy |
821,306
+123,680
| +18% | +$1.21M | 0.27% | 97 |
|
|
2023
Q3 | $5.83M | Buy |
697,626
+87,366
| +14% | +$730K | 0.21% | 121 |
|
|
2023
Q2 | $8.12M | Sell |
610,260
-155,867
| -20% | -$2.07M | 0.25% | 102 |
|
|
2023
Q1 | $8.87M | Buy |
766,127
+88,969
| +13% | +$1.03M | 0.27% | 96 |
|
|
2022
Q4 | $5.54M | Buy |
677,158
+102,969
| +18% | +$842K | 0.17% | 124 |
|
|
2022
Q3 | $3.33M | Sell |
574,189
-147,219
| -20% | -$855K | 0.11% | 145 |
|
|
2022
Q2 | $3.19M | Buy |
721,408
+309,225
| +75% | +$1.37M | 0.11% | 141 |
|
|
2022
Q1 | $3.75M | Sell |
412,183
-76,712
| -16% | -$698K | 0.09% | 147 |
|
|
2021
Q4 | $10M | Buy |
488,895
+36,593
| +8% | +$749K | 0.21% | 112 |
|
|
2021
Q3 | $11.6M | Buy |
452,302
+170,315
| +60% | +$4.35M | 0.22% | 104 |
|
|
2021
Q2 | $9.86M | Buy |
+281,987
| New | +$9.86M | 0.18% | 117 |
|